Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Spruce Biosciences, Inc.

Spruce Biosciences, Inc.

Stage unknownSouth San Francisco, CAsprucebiosciences.comBiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
No Revenuessec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
5
Financing history
1 rounds
  1. Oct 9, 2025
    Form D equity offering · $50.0M (form d sold) · 21 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Spruce Biosciences, Inc. filed Form D: $49,999,768 sold of $49,999,768, Biotechnology”
Investors on record
5 edges
People
3 officers, 6 directors
Timeline
2
  1. Sep 16, 2026
    Spruce Biosciences, Inc. no longer listed on Omega Fund Management, LLC's portfolio page
    Removed from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
  2. Oct 17, 2025
    Spruce Biosciences, Inc. filed Form D: $49,999,768 sold of $49,999,768, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
23 observations
Every observation on this company